These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1461082)

  • 1. Copper-D-penicillamine complex as potential contrast agent for MRI.
    Kupka T; Dziegielewski JO; Pasterna G; Małecki JG
    Magn Reson Imaging; 1992; 10(5):855-8. PubMed ID: 1461082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper complexes as a source of redox active MRI contrast agents.
    Dunbar L; Sowden RJ; Trotter KD; Taylor MK; Smith D; Kennedy AR; Reglinski J; Spickett CM
    Biometals; 2015 Oct; 28(5):903-12. PubMed ID: 26253716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menkes' disease: long-term treatment with copper and D-penicillamine.
    Nadal D; Baerlocher K
    Eur J Pediatr; 1988 Aug; 147(6):621-5. PubMed ID: 3181204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and possible applications of biotin-linked copper clusters.
    Bigham SL; Ballard JD; Giles KD; Clelland CS; Jeffcoat R; Griffin KS; Farley TD; Bushman DR; Wright JR
    Physiol Chem Phys Med NMR; 1990; 22(2):63-72. PubMed ID: 2100006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation into copper catalyzed D-penicillamine oxidation and subsequent hydrogen peroxide generation.
    Gupte A; Mumper RJ
    J Inorg Biochem; 2007 Apr; 101(4):594-602. PubMed ID: 17275091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent administration of D-penicillamine and zinc has no advantages over the use of either single agent on copper excretion in the rat.
    Domingo JL; Gómez M; Jones MM
    Toxicology; 1998 Apr; 126(3):195-201. PubMed ID: 9674967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced intracellular delivery of the reactive oxygen species (ROS)-generating copper chelator D-penicillamine via a novel gelatin--D-penicillamine conjugate.
    Gupte A; Wadhwa S; Mumper RJ
    Bioconjug Chem; 2008 Jul; 19(7):1382-8. PubMed ID: 18570451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes.
    Lipsky PE
    J Clin Invest; 1984 Jan; 73(1):53-65. PubMed ID: 6606652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution of copper-rich granules in hepatic lysosomes by D-penicillamine prevents the development of fulminant hepatitis in Long-Evans cinnamon rats.
    Klein D; Lichtmannegger J; Heinzmann U; Summer KH
    J Hepatol; 2000 Feb; 32(2):193-201. PubMed ID: 10707858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with andrographolide and d-penicillamine enhanced therapeutic advantage over monotherapy with d-penicillamine in attenuating fibrogenic response and cell death in the periportal zone of liver in rats during copper toxicosis.
    Roy DN; Sen G; Chowdhury KD; Biswas T
    Toxicol Appl Pharmacol; 2011 Jan; 250(1):54-68. PubMed ID: 20946909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology of copper. A circular dichroism study on copper complexes of thionein and penicillamine.
    Rupp H; Voelter W; Weser U
    Hoppe Seylers Z Physiol Chem; 1975 Jun; 356(6):755-65. PubMed ID: 241690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-penicillamine prevents the development of hepatitis in Long-Evans Cinnamon rats with abnormal copper metabolism.
    Togashi Y; Li Y; Kang JH; Takeichi N; Fujioka Y; Nagashima K; Kobayashi H
    Hepatology; 1992 Jan; 15(1):82-7. PubMed ID: 1370162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of adjunctive copper sulphate treatment in patients with rheumatoid arthritis who have relapsed while taking D-penicillamine.
    Pullar T; Wrigley H; Newton K; Toothill C; Wright V
    Br J Clin Pharmacol; 1991 Jan; 31(1):105-7. PubMed ID: 2015161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper chelating agents. A comparison of cupruretic responses to various tetramines and D-penicillamine.
    Borthwick TR; Benson GD; Schugar HJ
    J Lab Clin Med; 1980 Apr; 95(4):575-80. PubMed ID: 7359013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A copper-activated magnetic resonance imaging contrast agent with improved turn-on relaxivity response and anion compatibility.
    Que EL; Gianolio E; Baker SL; Aime S; Chang CJ
    Dalton Trans; 2010 Jan; (2):469-76. PubMed ID: 20023983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo detection of copper ions by magnetic resonance imaging using a prion-based contrast agent.
    Makino S; Umemoto T; Yamada H; Yezdimer EM; Tooyama I
    Appl Biochem Biotechnol; 2012 Oct; 168(3):504-18. PubMed ID: 22810201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. d-penicillamine reduces serum oxidative stress in Alzheimer's disease patients.
    Squitti R; Rossini PM; Cassetta E; Moffa F; Pasqualetti P; Cortesi M; Colloca A; Rossi L; Finazzi-Agró A
    Eur J Clin Invest; 2002 Jan; 32(1):51-9. PubMed ID: 11851727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chiral separation with ligand-exchange micellar electrokinetic chromatography using a D-penicillamine-copper(II) ternary complex as chiral selector.
    Zheng ZX; Lin JM; Qu F; Hobo T
    Electrophoresis; 2003 Dec; 24(24):4221-6. PubMed ID: 14679569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-Penicillamine: analysis of the mechanism of copper-catalyzed hydrogen peroxide generation.
    Starkebaum G; Root RK
    J Immunol; 1985 May; 134(5):3371-8. PubMed ID: 2984288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference circular dichroism studies of copper and nickel binding to D-penicillamine in the presence of human serum albumin.
    Mohanakrishnan P; Chignell CF
    Biochem Pharmacol; 1985 Mar; 34(5):675-7. PubMed ID: 3977943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.